Stonebridge Capital Management Inc Abb Vie Inc. Transaction History

Stonebridge Capital Management Inc

$252 Million
Q3 2024

A detailed history of Stonebridge Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 3,347 shares of ABBV stock, worth $574,780. This represents 0.26% of its overall portfolio holdings.

Number of Shares

3,347

Previous 3,347 -0.0%

Holding current value

$574,780

Previous $574,000 15.16%

% of portfolio

0.26%

Previous 0.24%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 13, 2023	SELL	$133.59 - $154.65 $66,795 - $77,325	-500 Reduced 13.0%	3,347 $499,000
Q1 2023 Apr 03, 2023	SELL	$144.61 - $166.54 $239,184 - $275,457	-1,654 Reduced 30.07%	3,847 $613,000
Q4 2022 Jan 06, 2023	SELL	$138.31 - $165.87 $290,174 - $347,995	-2,098 Reduced 27.61%	5,501 $889,000
Q3 2022 Oct 06, 2022	SELL	$134.21 - $153.93 $94,483 - $108,366	-704 Reduced 8.48%	7,599 $1.02 Million
Q2 2022 Jul 01, 2022	SELL	$137.62 - $174.96 $96,884 - $123,171	-704 Reduced 7.82%	8,303 $1.27 Million
Q4 2021 Jan 05, 2022	SELL	$107.43 - $135.93 $75,201 - $95,151	-700 Reduced 7.21%	9,007 $1.22 Million
Q1 2021 Apr 05, 2021	BUY	$102.3 - $112.62 $10,230 - $11,262	100 Added 1.04%	9,707 $1.05 Million
Q3 2020 Dec 11, 2020	SELL	$85.91 - $100.83 $214,775 - $252,075	-2,500 Reduced 20.65%	9,607 $842,000
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $36,641 - $43,125	475 Added 4.08%	12,107 $976,000
Q2 2018 Jul 06, 2018	SELL	$89.78 - $106.23 $44,890 - $53,115	-500 Reduced 4.12%	11,632 $1.1 Million
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $1.09 Million - $1.19 Million	12,132	12,132 $1.22 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Account

Stonebridge Capital Management Inc Abb Vie Inc. Transaction History